Pulsatilla decoction alleviates colitis by enhancing autophagy and regulating PI3K‑Akt‑mTORC1 signaling pathway

Wang,Xuewei; Xu,Lijun; Wang,Tao; Xu,Jian; Fan,Fugang; Zhang,Yu; Wang,Jinpin; Cao,Qin

doi:10.3892/mmr.2022.12624

Pulsatilla decoction alleviates colitis by enhancing autophagy and regulating PI3K‑Akt‑mTORC1 signaling pathway

Authors:
- Xuewei Wang
- Lijun Xu
- Tao Wang
- Jian Xu
- Fugang Fan
- Yu Zhang
- Jinpin Wang
- Qin Cao
View Affiliations

Affiliations: Division of Gastroenterology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200062, P.R. China
Published online on: January 31, 2022 https://doi.org/10.3892/mmr.2022.12624
Article Number: 108
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the therapeutic effect of Pulsatilla decoction (PD) on ulcerative colitis (UC) and to elucidate its potential molecular mechanisms. C57BL/6 mice expressing natural killer (NK)1.1 were used as experimental animals in the present study and a model of oxazolone‑induced colitis was established. Mice were randomly divided into the following five groups: i) PD group; ii) oxazolone‑induced colitis group; iii) IL‑13 intervention group; iv) 5‑aminosalicylic acid positive control group; and v) negative control group (equal volume saline gavage). A total of 10 animals were used in each group. The effects of PD on UC and the association between this regimen and the PI3K‑Akt‑mTORC1 signaling pathway were evaluated by disease activity index (DAI), hematoxylin and eosin staining, reverse transcription‑quantitative PCR (RT‑qPCR), immunofluorescence assay, ELISA and western blotting. The UC models were successfully established by injecting oxazolone gavage solution. Clinical colitis evaluation and histological examination revealed that PD reduced the DAI values in oxazolone‑induced colitis in mice and the degree of infiltration in NK1.1 cells. PD significantly reduced the secretion of IL‑13, as determined using an ELISA. In addition, western blotting and RT‑qPCR analyses demonstrated that Beclin1 and LC3II/I expression levels were downregulated following treatment of the mice with PD. In addition, PD not only partially restored alterations in the expression of tight junction proteins in the colon tissues, but also suppressed the activation of the PI3K‑Akt‑mTORC1 signaling pathway. The data indicated that this regimen could alleviate oxazolone‑induced UC in mice, which could significantly reduce tissue inflammation and autophagy. The mechanism of action was associated with the PI3K‑Akt‑mTORC1 signaling pathway.

View Figures

View References

1	Feuerstein JD, Moss AC and Farraye FA: Ulcerative Colitis. Mayo Clin Proc. 94:1357–1373. 2019. View Article : Google Scholar : PubMed/NCBI
2	Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG and Long MD: ACG Clinical Guideline: Ulcerative Colitis in Adults. Am J Gastroenterol. 114:384–413. 2019. View Article : Google Scholar : PubMed/NCBI
3	Nakov R: New markers in ulcerative colitis. Clin Chim Acta. 497:141–146. 2019. View Article : Google Scholar : PubMed/NCBI
4	Ko CW, Singh S, Feuerstein JD, Falck-Ytter C, Falck-Ytter Y and Cross RK; American Gastroenterological Association Institute Clinical Guidelines Committee, : AGA Clinical practice guidelines on the management of Mild-to-Moderate ulcerative colitis. Gastroenterology. 156:748–764. 2019. View Article : Google Scholar : PubMed/NCBI
5	Cross R, Ko CW and Singh S: Mild-to-Moderate ulcerative colitis guideline. Gastroenterology. 156:7682019. View Article : Google Scholar : PubMed/NCBI
6	Teschke R, Wolff A, Frenzel C, Eickhoff A and Schulze J: Herbal traditional Chinese medicine and its evidence base in gastrointestinal disorders. World J Gastroenterol. 21:4466–4490. 2015. View Article : Google Scholar : PubMed/NCBI
7	Fan Y, Yi W, Huang H, Mei Z and Feng Z: Efficacy of herbal medicine (Gegen Qinlian Decoction) on ulcerative colitis: A systematic review of randomized controlled trials. Medicine (Baltimore). 98:e185122019. View Article : Google Scholar : PubMed/NCBI
8	Shen Z, Zhou Q, Ni Y, He W, Shen H and Zhu L: Traditional Chinese medicine for mild-to-moderate ulcerative colitis: Protocol for a network meta-analysis of randomized controlled trials. Medicine. 98:e168812019. View Article : Google Scholar : PubMed/NCBI
9	Lin JC, Wu JQ, Wang F, Tang FY, Sun J, Xu B, Jiang M, Chu Y, Chen D, Li X, et al: QingBai decoction regulates intestinal permeability of dextran sulphate sodium-induced colitis through the modulation of notch and NF-κB signalling. Cell Prolif. 52:e125472019. View Article : Google Scholar : PubMed/NCBI
10	Wang XM, Tian G, Duan QJ, Wu DQ, Shao J, Wang TM and Wang CZ: Therapeutic potential of n-butanol extract of Pulsatilla decoction in a murine model of ulcerative colitis induced by DSS combined with Candida albicans colonization. Zhongguo Zhong Yao Za Zhi. 43:2979–2984. 2018.(In Chinese). PubMed/NCBI
11	Wang WH, Zhan ZL, Peng HS, Yang J and Qian JP: Textual research on the origin and producing area of Baitouweng (Radix Pulsatillae). Zhonghua Yi Shi Za Zhi. 47:14–18. 2017.(In Chinese). PubMed/NCBI
12	Yu Z, Liu HJ, Dun HH, Dong Q and Liang C: Effect of Pulsatilla decoction on the expression of proinflammatory cytokines in inflammatory bowel disease. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 27:416–419. 2011.(In Chinese). PubMed/NCBI
13	Pontoglio M: Hepatocyte nuclear factor 1, a transcription factor at the crossroads of glucose homeostasis. J Am Soc Nephrol. 11 (Suppl 16):S140–S143. 2000. View Article : Google Scholar : PubMed/NCBI
14	Wang X, Fan F and Cao Q: Modified Pulsatilla decoction attenuates oxazolone-induced colitis in mice through suppression of inflammation and epithelial barrier disruption. Mol Med Rep. 14:1173–1179. 2016. View Article : Google Scholar : PubMed/NCBI
15	Lu SW, Liu HJ, Zhao W, Li L, Dun HH and Liang C: Molecular mechanisms involved in the treatment of inflammatory bowel disease by Pulsatilla decoction. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 27:106–109. 2011.(In Chinese). PubMed/NCBI
16	Hua YL, Ma Q, Zhang XS, Jia YQ, Peng XT, Yao WL, Ji P, Hu JJ and Wei YM: Pulsatilla decoction can treat the dampness-heat diarrhea rat model by regulating glycerinphospholipid metabolism based lipidomics approach. Front Pharmacol. 11:1972020. View Article : Google Scholar : PubMed/NCBI
17	Liu X, He S, Li Q, Mu X, Hu G and Dong H: Comparison of the Gut microbiota between pulsatilla decoction and levofloxacin hydrochloride therapy on Escherichia coli Infection. Front Cell Infect Microbiol. 10:3192020. View Article : Google Scholar : PubMed/NCBI
18	Wang X, Yang J, Cao Q and Tang J: Therapeutic efficacy and mechanism of water-soluble extracts of Banxiaxiexin decoction on BALB/c mice with oxazolone-induced colitis. Exp Ther Med. 8:1201–1204. 2014. View Article : Google Scholar : PubMed/NCBI
19	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
20	Ji AL, Li T, Zu G, Feng DC, Li Y, Wang GZ, Yao JH and Tian XF: Ubiquitin-specific protease 22 enhances intestinal cell proliferation and tissue regeneration after intestinal ischemia reperfusion injury. World J Gastroenterol. 25:824–836. 2019. View Article : Google Scholar : PubMed/NCBI
21	Gordon IO, Agrawal N, Willis E, Goldblum JR, Lopez R, Allende D, Liu X, Patil DY, Yerian L, El-Khider F, et al: Fibrosis in ulcerative colitis is directly linked to severity and chronicity of mucosal inflammation. Aliment Pharmacol Ther. 47:922–939. 2018. View Article : Google Scholar : PubMed/NCBI
22	Qian XX, Cai CW, Li HY, Lai LJ, Song DJ, Qiao YQ, Shen J and Ran ZH: Transcribed ultraconserved region (T-UCR) uc.261 expression is closely correlated with disease activity and intestinal permeability in Crohn's disease. Ther Adv Gastroenter. 12:17562848198807332019.PubMed/NCBI
23	Guo BJ, Bian ZX, Qiu HC, Wang YT and Wang Y: Biological and clinical implications of herbal medicine and natural products for the treatment of inflammatory bowel disease. Ann N Y Acad Sci. 1401:37–48. 2017. View Article : Google Scholar : PubMed/NCBI
24	Suh SY and An WG: Systems pharmacological approach of pulsatillae radix on treating Crohn's disease. Evid Based Complement Alternat Med. 2017:41980352017. View Article : Google Scholar : PubMed/NCBI
25	Wang Q, Su CP, Zhang HM, Ren YL, Wang W and Guo SZ: Anti-inflammatory mechanism of heat-clearing and detoxifying Chinese herbs. Zhongguo Zhong Yao Za Zhi. 43:3787–3794. 2018.(In Chinese). PubMed/NCBI
26	Li S, Li X, Yang R, Wang B, Li J, Cao L, Xiao S and Huang W: Effects of anemoside B4 on pharmacokinetics of florfenicol and mRNA expression of CXR, MDR1, CYP3A37 and UGT1E in broilers. J Vet Med Sci. 81:1804–1809. 2019. View Article : Google Scholar : PubMed/NCBI
27	Shi Y, Zhao M, Yao H, Yang P, Xin T, Li B, Sun W and Chen S: Rapidly discriminate commercial medicinal Pulsatilla chinensis (Bge.) Regel from its adulterants using ITS2 barcoding and specific PCR-RFLP assay. Sci Rep. 7:400002017. View Article : Google Scholar : PubMed/NCBI
28	Frisardi V, Panza F, Seripa D, Farooqui T and Farooqui AA: Glycerophospholipids and glycerophospholipid-derived lipid mediators: A complex meshwork in Alzheimer's disease pathology. Prog Lipid Res. 50:313–330. 2011. View Article : Google Scholar : PubMed/NCBI
29	Tatiya-Aphiradee N, Chatuphonprasert W and Jarukamjorn K: Immune response and inflammatory pathway of ulcerative colitis. J Basic Clin Physiol Pharmacol. 30:1–10. 2018. View Article : Google Scholar : PubMed/NCBI
30	Salem HA and Wadie W: Effect of Niacin on Inflammation and Angiogenesis in a Murine Model of Ulcerative Colitis. Sci Rep. 7:71392017. View Article : Google Scholar : PubMed/NCBI
31	Leung VSY, Benoit-Biancamano MO and Pang DSJ: Performance of behavioral assays: The Rat Grimace Scale, burrowing activity and a composite behavior score to identify visceral pain in an acute and chronic colitis model. Pain Rep. 4:e7182019. View Article : Google Scholar : PubMed/NCBI
32	Hanauer SB: Oral or topical 5-ASA in ulcerative colitis. Dig Dis. 34:122–124. 2016. View Article : Google Scholar : PubMed/NCBI
33	Lai LJ, Shen J and Ran ZH: Natural killer T cells and ulcerative colitis. Cell Immunol. 335:1–5. 2019. View Article : Google Scholar : PubMed/NCBI
34	Chang HK and Hou WS: Retinoic acid modulates interferon-γ production by hepatic natural killer T cells via phosphatase 2A and the extracellular signal-regulated kinase pathway. J Interferon Cytokine Res. 35:200–212. 2015. View Article : Google Scholar : PubMed/NCBI
35	Wu S, Yang C, Xu N, Wang L, Liu Y, Wang J and Shen X: The protective effects of Helix B surface peptide on experimental acute liver injury induced by carbon tetrachloride. Dig Dis Sci. 62:1537–1549. 2017. View Article : Google Scholar : PubMed/NCBI
36	Zhang L, Tschumi BO, Corgnac S, Rüegg MA, Hall MN, Mach JP, Romero P and Donda A: Mammalian target of rapamycin complex 1 orchestrates invariant NKT cell differentiation and effector function. J Immunol. 193:1759–1765. 2014. View Article : Google Scholar : PubMed/NCBI
37	Landy J, Ronde E, English N, Clark SK, Hart AL, Knight SC, Ciclitira PJ and Al-Hassi HO: Tight junctions in inflammatory bowel diseases and inflammatory bowel disease associated colorectal cancer. World J Gastroenterol. 22:3117–3126. 2016. View Article : Google Scholar : PubMed/NCBI
38	Chen T, Xue H, Lin R and Huang Z: MiR-34c and PlncRNA1 mediated the function of intestinal epithelial barrier by regulating tight junction proteins in inflammatory bowel disease. Biochem Biophys Res Commun. 486:6–13. 2017. View Article : Google Scholar : PubMed/NCBI
39	He C, Deng J, Hu X, Zhou S, Wu J, Xiao D, Darko KO, Huang Y, Tao T, Peng M, et al: Vitamin A inhibits the action of LPS on the intestinal epithelial barrier function and tight junction proteins. Food Funct. 10:1235–1242. 2019. View Article : Google Scholar : PubMed/NCBI